Samalin Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,064
| Closed | -$264K | – | 310 |
|
|
2025
Q1 | $264K | Buy |
2,064
+2
| +0.1% | +$256 | 0.11% | 258 |
|
|
2024
Q4 | $273K | Hold |
2,062
| – | – | 0.12% | 234 |
|
|
2024
Q3 | $300K | Buy |
2,062
+3
| +0.1% | +$437 | 0.13% | 226 |
|
|
2024
Q2 | $283K | Hold |
2,059
| – | – | 0.13% | 226 |
|
|
2024
Q1 | $283K | Buy |
2,059
+77
| +4% | +$10.6K | 0.13% | 225 |
|
|
2023
Q4 | $269K | Sell |
1,982
-155
| -7% | -$21.1K | 0.14% | 221 |
|
|
2023
Q3 | $261K | Buy |
2,137
+250
| +13% | +$30.6K | 0.15% | 192 |
|
|
2023
Q2 | $240K | Sell |
1,887
-1
| -0.1% | -$127 | 0.13% | 218 |
|
|
2023
Q1 | $244K | Buy |
1,888
+84
| +5% | +$10.8K | 0.15% | 195 |
|
|
2022
Q4 | $237K | Buy |
1,804
+49
| +3% | +$6.43K | 0.15% | 188 |
|
|
2022
Q3 | $205K | Buy |
1,755
+2
| +0.1% | +$234 | 0.15% | 193 |
|
|
2022
Q2 | $206K | Hold |
1,753
| – | – | 0.15% | 193 |
|
|
2022
Q1 | $228K | Buy |
1,753
+52
| +3% | +$6.76K | 0.14% | 211 |
|
|
2021
Q4 | $260K | Buy |
+1,701
| New | +$260K | 0.16% | 189 |
|
|
2020
Q1 | – | Sell |
-1,123
| Closed | -$135K | – | 295 |
|
|
2019
Q4 | $135K | Buy |
+1,123
| New | +$135K | 0.11% | 188 |
|